Is a complete ATYR research report available?

No complete published report is available for aTyr Pharma, Inc. (ATYR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

aTyr Pharma, Inc. (ATYR)

NASDAQ: ATYR · USD

$0.48

-0.00 (-0.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ATYR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	47.1M
Revenue (ttm)	190K
Net income (ttm)	-70M
EPS (ttm)	-$0.73
Shares out	98.1M
Volume	627,373
Beta	0.52
Price target	$2.86	+495.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 190K
Net income (ttm): -70M
EPS (ttm): -$0.73
Market cap: 47.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ATYR indicators

Market & fundamental data

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001339970
Company name	aTyr Pharma, Inc.
Country	United States
Country code	US
Cusip	002120202
Employees	60
Employees Change	1%
Employees Change Percent	1.69
Enterprise value	$-7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2015-05-07
Isin	US0021202025
Last refreshed	2026-07-31
Market cap	$47.1M
Market cap category	Nano-Cap
Price	$0.48
Price currency	USD
Rev Per Employee	3,166.67x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2836
Symbol	ATYR
Website	https://atyrpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-146.53%
FCF yield	-124.08%
P/B ratio	0.82x
P/S ratio	251.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-55.5M
Net Income	$-70M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-36,860%
Profit Per Employee	$-1.2M
ROA	-51.79
Roa5y	-35.38
ROCE	-107.9
ROE	-105.6
Roe5y	-69.72
ROIC	-58.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-36.87%
Cagr1y	-90.86%
Cagr3y	-37.95%
Cagr5y	-36.31%
EPS Growth Quarters	2
EPS Growth Years	4
Revenue Growth	-19.15x
Revenue Growth Years	0x
Revenue Growth3 Y	-73.65x
Revenue Growth5 Y	-39.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$79.7M
Cash	$66.5M
Current Assets	$67.6M
Current Liabilities	$11.7M
Debt	$11.7M
Debt Equity	$0.2
Equity	$57.7M
Liabilities	$21.9M
Long Term Assets	$12.1M
Long Term Liabilities	$10.2M
Net Cash	$54.8M
Net Cash By Market Cap	$115
Net Cash Growth	-13.49%
Net Debt Equity	$-0.95
Tangible Book Value	$57.9M
Tangible Book Value Per Share	$0.59
WACC	5.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.78
Net Working Capital	$-9.2M
Quick ratio	5.73
Working Capital	$55.9M
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-20.81%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-98.99%
1Y total return	-90.85%
200-day SMA	0.74
3Y total return	-76.12%
50-day SMA	0.51
50-day SMA vs 200-day SMA	50under200
5Y total return	-89.52%
All Time High	396.1
All Time High Change	-99.88%
All Time High Date	2015-06-04
All Time Low	0.4
All Time Low Change	21.52%
All Time Low Date	2026-05-13
ATR	0.04
Beta	0.52
Beta1y	1.2
Beta2y	1.19
Ch YTD	-38.71
High	0.49
High52	6.5
High52 Date	2025-09-12
High52ch	-92.62%
Low	0.48
Low52	0.4
Low52 Date	2026-05-13
Low52ch	21.52%
Ma50ch	-6.32%
Premarket Change Percent	1.47
Premarket Price	$0.49
Premarket Volume	2,040
Price vs 200-day SMA	-35.48%
RSI	43.11
RSI Monthly	36.56
RSI Weekly	36.15
Sharpe ratio	-0.63x
Sortino ratio	-0.75
Total Return	-20.81%
Tr YTD	-38.71
Tr1m	-15.25%
Tr1w	-3.63%
Tr3m	-37.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	5
Analyst Price Target Top	$3
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.12
Operating Income	$-73.3M
Operating margin	-38,573.7
Price target	$2.86
Price Target Change	$496
Price Target Change Top	$525

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	95,511,137%
Float Percent	97.41%
Net Borrowing	-550,000
Shares Insiders	2.59%
Shares Institutions	41.37%
Shares Out	98,051,212
Shares Qo Q	0.03%
Shares Yo Y	20.81%
Short Float	8.67%
Short Ratio	3.43
Short Shares	8.44

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-64.4M
Adjusted OCF	-64,209,000
Average Volume	1,423,243.9x
Bv Per Share	0.59
CAPEX	$-215,000
Ch10y	-98.99
Ch1m	-15.25
Ch1w	-3.63
Ch1y	-90.85
Ch3m	-37.25
Ch3y	-76.12
Ch5y	-89.52
Ch6m	-43.57
Change	-0.62%
Change From Open	0
Close	0.48
Days Gap	-0.62
Depreciation Amortization	659,000
Dollar Volume	301,139
Earnings Date	2026-08-07
Earnings Time	amc
EBIT	$-73.3M
EBITDA	$-72.6M
EPS	$-0.73
F Score	1
FCF	$-59.3M
FCF EV Yield	844.36x
FCF Per Share	$-0.6
Financing CF	47,241,000
Fiscal Year End	December
Founded	2,005
Investing CF	10,861,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2019-07-01
Last Split Type	Reverse
Last10k Filing Date	2026-03-05
Ma150	0.72
Ma150ch	-33.09%
Ma20	0.53
Ma20ch	-9%
Net CF	-981,000
Next Earnings Date	2026-08-10
Open	0.48
Optionable	Yes
Position In Range	24.24
Post Close	0.48
Postmarket Change Percent	0.6
Postmarket Price	$0.48
Ppne	10,125,000
Pre Close	0.48
Price Date	2026-07-30
Ptbv Ratio	0.82
Relative Volume	0.44x
Revenue	190,000x
SBC By Revenue	2,697.89x
Share Based Comp	5,126,000
Tr6m	-43.57%
Us State	California
Volume	627,373
Z Score	-6.6

aTyr Pharma, Inc. (ATYR)

Coverage state: Market snapshot only — no published research

Generate the first ATYR analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ATYR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ATYR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ATYR

Frequently asked questions